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Background
It could be argued that adaptive designs are underused in
clinical trials research. However, of the adaptive trials that
have been undertaken there are concerns which could be
linked to inadequate reporting of trial conduct. We exam-
ined compliance in the reporting of group sequential ran-
domised controlled trials (RCTs) to investigate the issues.
Methods
We undertook a systematic review by searching Ovid
MEDLINE (01/01/2001 to 23/09/2014), supplemented
with RCTs from an audit study. We included parallel
group, confirmatory, group sequential RCTs that were
prospectively designed using a Frequentist approach.
Eligible RCTs were examined for reporting compliance
against the CONSORT 2010 checklist. Proposed modifica-
tions were added to capture group sequential aspects such
as use statistical bias correction due to early stopping.
Results
24% (68/284) RCTs were eligible; most were published
in high impact journals. We found that 46(68%) were
stopped early, predominantly either for futility or effi-
cacy. Group sequential aspects were largely inadequately
reported. Only 7% (3/46) RCTs which stopped early
reported use of statistical bias correction. 52(76%) RCTs
failed to disclose methods used to minimise the risk of
operational bias through the knowledge or leaking of
interim results. Suboptimal compliance was found in
items relating to: access to trial protocols: randomisation
methods; details of randomisation concealment, and its
implementation. Changes to trial methods and outcomes
could not be determined in most trials, due to inaccessible
protocols and amendments.
Conclusions
Suboptimal reporting may lead to researchers questioning
the robustness of trial conclusions of RCTs that stop early
to change practice. Modification of the CONSORT state-
ment to incorporate adaptive designs could be helpful.
Assurance of scientific rigour through transparent and
adequate reporting is paramount to the acceptability of
findings from adaptive RCTs.
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